SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that two research abstracts evaluating its AI-powered electrocardiogram (AI-ECG) technology within the Viz Cardio Suite have been accepted for presentation at the Hypertrophic Cardiomyopathy Medical Society (HCMS) meeting, held in conjunction with the American Heart Association’s Scientific Sessions 2026 in Chicago. Both studies focus on Viz HCM, the suite’s AI-E
See full post here as originally published on this site
